JP Morgan analyst Mark Murphy upgrades ServiceNow (NYSE:NOW) from Neutral to Overweight.
Where Xenon Pharmaceuticals Stands With Analysts
Analysts have provided the following ratings for Xenon Pharmaceuticals (NASDAQ:XENE) within the last quarter: Bullish Somewhat Bullish Indifferent…